Le Lézard
Classified in: Business
Subject: ATY

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Sage Therapeutics, Inc. - SAGE


NEW YORK, May 6, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Sage Therapeutics, Inc. ("Sage" or the "Company") (NASDAQ: SAGE).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

The investigation concerns whether Sage and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

[Click here for information about joining the class action] 

On April 17, 2024, Sage issued a press release "announc[ing] . . . topline results from PRECEDENT, a double-blind, placebo-controlled Phase 2 study of the investigational oral medicine dalzanemdor (SAGE-718) in people with mild cognitive impairment (MCI) in Parkinson's Disease (PD)."  Sage stated that "[t]he PRECEDENT Study did not meet its primary endpoint of demonstrating statistically significant difference from baseline in participants treated with once-daily dalzanemdor versus placebo". 

On this news, Sage's stock price fell $3.06 per share, or 19.58%, to close at $12.57 per share on April 17, 2024.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered billions of dollars in damages awards on behalf of class members. See www.pomlaw.com.

Attorney advertising.  Prior results do not guarantee similar outcomes.

CONTACT:
Danielle Peyton
Pomerantz LLP
[email protected]
646-581-9980 ext. 7980

SOURCE Pomerantz LLP


These press releases may also interest you

at 17:10
Acceleware® Ltd. ("Acceleware" or the "Corporation") , a leading innovator of transformative technologies targeting the decarbonization of industrial process heat, as of February 10, 2025, has granted stock options to acquire up to 1,634,000 common...

at 17:10
Delta Galil Industries, Ltd. (DELG/Tel Aviv Stock Exchange), the global designer, manufacturer and marketer of branded and private label intimate, activewear, loungewear and denim apparel for ladies, men, and children, today reported financial...

at 17:10
Trulite, a leading provider of architectural glass and aluminum solutions, is pleased to announce the acquisition of Dependable Glass Works headquartered in Covington, LA effective February 3, 2025. Dependable is a well-respected player in the glass...

at 17:05
PAMT CORP ("we" or the "Company") today reported consolidated net loss of $31.6 million, or diluted and basic loss per share of $1.45, for the quarter ended December 31, 2024 and consolidated net loss of $31.8 million, or diluted and basic loss per...

at 17:05
International Seaways, Inc. (the "Company" or "INSW") announced today that it plans to release fourth quarter and full year 2024 results before market open on Thursday, February 27, 2025. The Company will host a conference call for investors at 9:00...

at 17:05
Computer Modelling Group Ltd. ("CMG Group" or the "Company") announces its financial results for the three and nine months ended December 31, 2024, and the approval by its Board of Directors (the "Board") of the payment of a cash dividend of $0.05...



News published on and distributed by: